Bamlanivimab

(Synonyms: Anti-Human SARS-CoV-2)
Customer Review

Based on 1 Customer Validation

Bamlanivimab (Anti-Human SARS-CoV-2) is the first COVID-19 monoclonal antibody (mAb) to be granted Emergency Use Authorization (EUA) in November 2020 by the U.S. Food and agent Administration (FDA). However, Bamlanivimab is withdrawn in April 2021 following the rise of SARS-CoV-2 virus variants resistant to Bamlanivimab.

For research use only. We do not sell to patients.

  • Purity: 99.97%
  • CAS No.: 2423943-37-5
  • Molecular Weight:144.5 kDa
  • Storage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biological Activity
  • Chemical Information
  • Purity & Documentation
  • References
  • Help & FAQs
100 mg

Get Quote In-stock

Please select quantity
Amount: USD 0.00